Evidence map›Paper›PMID 36835450›Full record

ReviewInternational journal of molecular sciences2023

Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports.

Iva Bešlić, Liborija Lugović-Mihić, Alen Vrtarić, Ante Bešlić, Ivana Škrinjar, Milena Hanžek, Danijel Crnković, Marinko Artuković

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Melatonin in Dermatology.Indian dermatology online journal · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Melatonin's Impact on Wound Healing.Antioxidants (Basel, Switzerland) · 2024
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Iva BešlićDepartment of Dermatovenereology, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.
Liborija Lugović-MihićDepartment of Dermatovenereology, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0001-7494-5742
Alen VrtarićDepartment of Clinical Chemistry, University Clinical Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0002-4104-1402
Ante BešlićFaculty of Dental Medicine and Health, Josip Juraj Strossmayer University, 31000 Osijek, Croatia.
Ivana ŠkrinjarSchool of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Milena HanžekDepartment of Clinical Chemistry, University Clinical Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0003-3009-0599
Danijel CrnkovićDepartment of Psychiatry, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.
Marinko ArtukovićDepartment of Polemology, Special Hospital for Pulmonary Diseases, 10000 Zagreb, Croatia.
Sisters of Charity Hospital · HRUniversity Hospital Centre Zagreb · HRUniversity of Zagreb · HRUniversity of Osijek · HR

Funding

CROATIAN MEDICAL ASSOCIATION (Hrvatski Liječnički Zbor), Hrvatsko društvo za alergologiju i kliničku imunologiju (HDAKI) NA
6 · The paper itself

Abstract

Melatonin is the main hormone that regulates the sleep cycle, and it is mostly produced by the pineal gland from the amino acid tryptophan. It has cytoprotective, immunomodulatory, and anti-apoptotic effects. Melatonin is also one of the most powerful natural antioxidants, directly acting on free radicals and the intracellular antioxidant enzyme system. Furthermore, it participates in antitumor activity, hypopigmentation processes in hyperpigmentary disorders, anti-inflammatory, and immunomodulating activity in inflammatory dermatoses, maintaining the integrity of the epidermal barrier and thermoregulation of the body. Due predominantly to its positive influence on sleep, melatonin can be used in the treatment of sleep disturbances for those with chronic allergic diseases accompanied by intensive itching (such as atopic dermatitis and chronic spontaneous urticaria). According to the literature data, there are also many proven uses for melatonin in photoprotection and skin aging (due to melatonin's antioxidant effects and role in preventing damage due to DNA repair mechanisms), hyperpigmentary disorders (e.g., melasma) and scalp diseases (such as androgenic alopecia and telogen effluvium).

Indexed as

Alopecia AreataDermatitis, AtopicMelatoninAntioxidantsHumansSkinAntioxidantsMelatoninallergic rhinitisallergyandrogenic alopeciaatopic dermatitismelasmamelatoninphotoprotectionrosaceaskin agingsleep disordersurticaria

Identifiers

PMID36835450
PMCPMC9967801
OpenAlexW4321243235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.